142 related articles for article (PubMed ID: 36858620)
1. Establishment and Characterization of an Acute Lymphocytic Leukemia Cell Line Expressing CD13 and CD33 with a Complex Philadelphia Translocation.
Sameshima Y; Okada M; Shiseki M; Mori N; Motoji T; Tanaka J
Intern Med; 2023; 62(5):697-701. PubMed ID: 36858620
[TBL] [Abstract][Full Text] [Related]
2. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
3. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia].
Lin ZK; Zhang R; Ge Z; Liu J; Wu YJ; Guo X; Qiao C; Qiu HR; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):289-95. PubMed ID: 23628018
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of human B cell precursor-leukemia cell lines.
Matsuo Y; Drexler HG
Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
[TBL] [Abstract][Full Text] [Related]
8. CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
Harata M; Soda Y; Tani K; Ooi J; Takizawa T; Chen M; Bai Y; Izawa K; Kobayashi S; Tomonari A; Nagamura F; Takahashi S; Uchimaru K; Iseki T; Tsuji T; Takahashi TA; Sugita K; Nakazawa S; Tojo A; Maruyama K; Asano S
Blood; 2004 Sep; 104(5):1442-9. PubMed ID: 15155467
[TBL] [Abstract][Full Text] [Related]
9. Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: a Single-center Experience.
Pant G; Kumar A; Verma N; Pooniya V; Sharma A; Gupta B
J Pediatr Hematol Oncol; 2019 Jul; 41(5):376-381. PubMed ID: 31033785
[TBL] [Abstract][Full Text] [Related]
10. Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.
Chevallier P; Mahe B; Garand R; Talmant P; Harousseau JL; Delaunay J
Int J Hematol; 2008 Sep; 88(2):209-211. PubMed ID: 18668307
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.
Jaso J; Thomas DA; Cunningham K; Jorgensen JL; Kantarjian HM; Medeiros LJ; Wang SA
Cancer; 2011 Sep; 117(17):4009-17. PubMed ID: 21365622
[TBL] [Abstract][Full Text] [Related]
12. [Acute lymphoblastic leukemia with "masked" Philadelphia chromosome].
Naganuma K; Tabayashi T; Kawada T; Sakata N; Takahashi Y; Kimura Y; Anan T; Mitsuhashi T; Kubota Y; Kizaki M
Rinsho Ketsueki; 2022; 63(11):1525-1529. PubMed ID: 36476792
[TBL] [Abstract][Full Text] [Related]
13. Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
Yoshimitsu M; Fujiwara H; Ozaki A; Hamada H; Matsushita K; Arima N; Tei C
Int J Hematol; 2008 Oct; 88(3):331-335. PubMed ID: 18696183
[TBL] [Abstract][Full Text] [Related]
14. Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy.
Ashraf S; Wolfson J; Vachhani P; Rangaraju S; Bachiashvili K; Bhatia R; Jamy O
J Adolesc Young Adult Oncol; 2022 Dec; 11(6):617-620. PubMed ID: 35049365
[TBL] [Abstract][Full Text] [Related]
15. Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia.
Mukae J; Sadato D; Toya T; Watanabe S; Hirama C; Konuma R; Shimizu H; Najima Y; Kobayashi T; Kato M; Ohki K; Oboki K; Harada H; Ohashi K; Deguchi T; Harada Y; Doki N
Leuk Lymphoma; 2022 Dec; 63(13):3261-3264. PubMed ID: 36102781
[No Abstract] [Full Text] [Related]
16. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].
He BL; Xu N; Li YL; Pan CY; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Zhou HS; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):204-209. PubMed ID: 28395443
[No Abstract] [Full Text] [Related]
18. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
Larson RS; McCurley TL
Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z
Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]